Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


China issues first manufacturing approvals for 2015

The Chinese Ministry of Industry and Information Technology (MIIT) has issued its first list of pesticide manufacturing approvals for 2015. The majority of the 231 authorisations are for pesticide processing or mixing of agrochemical compounds, while only three companies were granted approvals for the manufacture of active ingredients. The first came for Henan Yale Biotechnology, which was awarded aregisration for the insecticide, matrine (5% mother liquid). The second company was Yancheng South Chemicals, with four herbicide approvals: metamitron (90%), tebuthiuron (97%), imazapic (98%) and imazapyr (98%). The last company to receive ai manufacturing authorisations was Xi’an Modern Pesticide, for the fungicides, propamocarb hydrochloride (90%) and bupirimate (97%). More approvals were given to companies in the northern coastal province of Shandong (79 approvals) than any other region, with Zhejiang coming in second (32 approvals). Shandong rivals Jiangsu province for being China’s main agrochemical manufacturing powerhouse.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts